Company Delivers Record Revenue for 2010
AUSTIN, Texas--(BUSINESS WIRE)--
Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance,
analog-intensive, mixed-signal integrated circuits (ICs), today reported
revenue of $112 million for the fourth quarter and record revenue for
the full year of $493 million.
2010 Highlights
-
Year over year growth was driven by record revenue for the company's
broad-based products, which grew by nearly 50 percent over 2009 and
represented 35 percent of total revenue for the year.
-
A sustained focus on R&D resulted in 17 new product family
introductions during the year spanning MCUs, Embedded Wireless,
Isolation, Human Interface, Timing, Video, AM/FM Radio and Power over
Ethernet.
-
The company achieved a record number of design wins, broadened its
sales channel and expanded its design team, all strong building blocks
for future growth.
-
Gross margin on both a GAAP and non-GAAP basis was at record levels
for the year resulting from cost improvements and mix shifts to
broad-based products.
-
The company delivered 18 percent GAAP operating income and 26 percent
non-GAAP operating income for the year.
-
Cash generation continued to be very strong, enabling $140 million in
share repurchases, two strategic technology acquisitions and a
year-end cash, cash equivalents and investments balance of $383
million.
Fourth Quarter Highlights
Fourth quarter revenue of $112 million exceeded guidance and represented
a seven percent sequential decrease. The better than anticipated result
for the quarter was due to stronger than anticipated demand for the
company's broad-based products and the early stages of the company's
ramp into iDTVs with its silicon TV tuner.
Fourth quarter GAAP gross margin was 63.5 percent. R&D investment
increased to $32.6 million while SG&A decreased again to $27.5 million.
Fully diluted GAAP earnings per share were $0.28 for the quarter.
The following non-GAAP results exclude the impact of stock compensation
expense. Non-GAAP gross margin was 63.9 percent for the quarter. R&D
investment increased sequentially to $28.5 million. SG&A expense
declined to $22.8 million. Fully diluted non-GAAP earnings per share
were $0.46. The reconciling charges are set forth in the financial
measures table included below.
2011 Business Outlook
The company anticipates 2011 will be another growth year, with strong
contributions from both the broadcast and broad-based businesses.
Specifically, the company expects its video business to ramp and triple
in size, while the timing business is expected to deliver high
double-digit growth again in 2011. Both product lines are benefiting
from new product ramps and an expanding footprint enabling strong market
share gains.
"We believe the investments we've been making in our business over the
last couple of years will begin delivering a strong return in 2011,"
said Necip Sayiner, president and CEO of Silicon Laboratories. "Organic
new product developments complemented by strategic acquisitions like the
SpectraLinear deal we announced today, have given us a platform for
continually expanding our share of the market. We expect to benefit from
such product cycles and are therefore anticipating a revenue increase of
approximately four to nine percent in the first quarter."
The company guided revenue for the first quarter in the range of $116 to
$122 million.
Webcast and Conference Call
A conference call discussing the quarterly results and the acquisition
of SpectraLinear, also announced today, will follow this press release
at 7:30 a.m. central time. An audio webcast will be available
simultaneously on Silicon Laboratories' website under Investor Relations
(www.silabs.com).
A replay will be available after the call at the same website listed
above or by calling 1 (800) 642-1687 or +1 (706) 645-9291
(international) and by entering 38360353. The replay will be available
through February 9, 2011.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance,
analog-intensive, mixed-signal integrated circuits (ICs) for a broad
range of applications. Silicon Laboratories' diverse portfolio of highly
integrated, patented solutions is developed by a world-class engineering
team with expertise in cutting-edge mixed-signal design. The company has
design, engineering, marketing, sales and applications offices
throughout North America, Europe and Asia. For more information about
Silicon Laboratories, please visit www.silabs.com.
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon
Laboratories' current expectations. The words "believe," "estimate,"
"expect," "intend," "anticipate," "plan," "project," "will" and similar
phrases as they relate to Silicon Laboratories are intended to identify
such forward-looking statements. These forward-looking statements
reflect the current views and assumptions of Silicon Laboratories and
are subject to various risks and uncertainties that could cause actual
results to differ materially from expectations. Among the factors that
could cause actual results to differ materially from those in the
forward-looking statements are the following: risks that Silicon
Laboratories may not be able to maintain its historical growth;
quarterly fluctuations in revenues and operating results; volatile stock
price; average selling prices of products may decrease significantly and
rapidly; difficulties developing new products that achieve market
acceptance; dependence on a limited number of products and customers;
intellectual property litigation risks; inventory-related risks; risks
associated with acquisitions; difficulties managing international
activities; difficulties managing our manufacturers and subcontractors;
risks that Silicon Laboratories may not be able to manage strains
associated with its growth; credit risks associated with our accounts
receivable; dependence on key personnel; risks associated with
divestitures; geographic concentration of manufacturers, assemblers,
test service providers and customers in Asia that subjects Silicon
Laboratories' business and results of operations to risks of natural
disasters, epidemics, war and political unrest; the competitive and
cyclical nature of the semiconductor industry and other factors that are
detailed in Silicon Laboratories' filings with the SEC. Silicon
Laboratories disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new information,
future events or otherwise.
Note to editors: Silicon Laboratories, Silicon Labs and the Silicon
Labs logo are trademarks of Silicon Laboratories Inc. All other product
names noted herein may be trademarks of their respective holders.
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
January 1,
2011
|
|
January 2,
2010
|
|
January 1,
2011
|
|
January 2,
2010
|
|
Revenues
|
|
$
|
111,891
|
|
|
$
|
127,190
|
|
|
$
|
493,341
|
|
|
$
|
441,020
|
|
|
Cost of revenues
|
|
|
40,800
|
|
|
|
43,930
|
|
|
|
169,097
|
|
|
|
161,267
|
|
|
Gross margin
|
|
|
71,091
|
|
|
|
83,260
|
|
|
|
324,244
|
|
|
|
279,753
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
32,621
|
|
|
|
26,553
|
|
|
|
123,821
|
|
|
|
104,394
|
|
|
Selling, general and administrative
|
|
|
27,456
|
|
|
|
30,629
|
|
|
|
113,752
|
|
|
|
108,848
|
|
|
Operating expenses
|
|
|
60,077
|
|
|
|
57,182
|
|
|
|
237,573
|
|
|
|
213,242
|
|
|
Operating income
|
|
|
11,014
|
|
|
|
26,078
|
|
|
|
86,671
|
|
|
|
66,511
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
479
|
|
|
|
640
|
|
|
|
2,318
|
|
|
|
2,725
|
|
|
Interest expense
|
|
|
(11
|
)
|
|
|
(25
|
)
|
|
|
(77
|
)
|
|
|
(180
|
)
|
|
Other income (expense), net
|
|
|
24
|
|
|
|
(388
|
)
|
|
|
(1,253
|
)
|
|
|
(90
|
)
|
|
Income before income taxes
|
|
|
11,506
|
|
|
|
26,305
|
|
|
|
87,659
|
|
|
|
68,966
|
|
|
Provision (benefit) for income taxes
|
|
|
(1,377
|
)
|
|
|
(13,946
|
)
|
|
|
14,417
|
|
|
|
(4,126
|
)
|
|
Net income
|
|
$
|
12,883
|
|
|
$
|
40,251
|
|
|
$
|
73,242
|
|
|
$
|
73,092
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.29
|
|
|
$
|
0.88
|
|
|
$
|
1.63
|
|
|
$
|
1.62
|
|
|
Diluted
|
|
$
|
0.28
|
|
|
$
|
0.84
|
|
|
$
|
1.57
|
|
|
$
|
1.57
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
43,834
|
|
|
|
45,650
|
|
|
|
44,845
|
|
|
|
45,023
|
|
|
Diluted
|
|
|
45,658
|
|
|
|
47,786
|
|
|
|
46,742
|
|
|
|
46,542
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Income Statement Items
|
|
Three Months Ended
January 1, 2011
|
|
|
|
GAAP
Measure
|
|
GAAP
Percent of Revenue
|
|
Stock
Compensation Expense
|
|
Non-GAAP
Measure
|
|
Non-GAAP
Percent of Revenue
|
|
Revenues
|
|
$
|
111,891
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
71,091
|
|
|
63.5
|
%
|
|
$
|
361
|
|
$
|
71,452
|
|
63.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
32,621
|
|
|
29.2
|
%
|
|
|
4,095
|
|
|
28,526
|
|
25.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
administrative
|
|
|
27,456
|
|
|
24.5
|
%
|
|
|
4,607
|
|
|
22,849
|
|
20.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
60,077
|
|
|
53.7
|
%
|
|
|
8,702
|
|
|
51,375
|
|
45.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
11,014
|
|
|
9.8
|
%
|
|
|
9,063
|
|
|
20,077
|
|
17.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Diluted Earnings Per Share
|
|
Three Months Ended
January 1, 2011
|
|
|
|
|
|
|
|
GAAP
Measure
|
|
Stock
Compensation Expense
|
|
Non-GAAP
Measure
|
|
|
|
|
|
Net income
|
|
$
|
12,883
|
|
$
|
7,929
|
|
|
$
|
20,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted shares outstanding
|
|
|
45,658
|
|
|
--
|
|
|
|
45,658
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
$
|
0.28
|
|
|
|
$
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Income Statement Items
|
|
Year Ended
January 1, 2011
|
|
|
|
GAAP
Measure
|
|
GAAP
Percent of Revenue
|
|
Stock
Compensation Expense
|
|
Non-GAAP
Measure
|
|
Non-GAAP
Percent of Revenue
|
|
Revenues
|
|
$
|
493,341
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
324,244
|
|
|
65.7
|
%
|
|
$
|
1,435
|
|
$
|
325,679
|
|
66.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
86,671
|
|
|
17.6
|
%
|
|
|
40,324
|
|
|
126,995
|
|
25.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
January 1,
2011
|
|
January 2,
2010
|
|
Assets
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
138,567
|
|
|
$
|
195,737
|
|
|
Short-term investments
|
|
|
227,295
|
|
|
|
214,486
|
|
|
Accounts receivable, net of allowance for doubtful accounts of
|
|
|
|
|
|
|
|
|
|
$772 at January 1, 2011 and $567 at January 2, 2010
|
|
|
45,030
|
|
|
|
56,128
|
|
|
Inventories
|
|
|
39,450
|
|
|
|
31,512
|
|
|
Deferred income taxes
|
|
|
9,140
|
|
|
|
7,620
|
|
|
Prepaid expenses and other current assets
|
|
|
34,447
|
|
|
|
18,515
|
|
|
Total current assets
|
|
|
493,929
|
|
|
|
523,998
|
|
|
Long-term investments
|
|
|
17,500
|
|
|
|
24,676
|
|
|
Property and equipment, net
|
|
|
29,945
|
|
|
|
27,785
|
|
|
Goodwill
|
|
|
112,296
|
|
|
|
105,109
|
|
|
Other intangible assets, net
|
|
|
53,242
|
|
|
|
41,886
|
|
|
Other assets, net
|
|
|
20,746
|
|
|
|
19,384
|
|
|
Total assets
|
|
$
|
727,658
|
|
|
$
|
742,838
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Accounts payable
|
|
$
|
24,433
|
|
|
$
|
28,759
|
|
|
Accrued expenses
|
|
|
25,604
|
|
|
|
25,399
|
|
|
Deferred income on shipments to distributors
|
|
|
26,127
|
|
|
|
28,470
|
|
|
Income taxes
|
|
|
3,692
|
|
|
|
6,011
|
|
|
Total current liabilities
|
|
|
79,856
|
|
|
|
88,639
|
|
|
Long-term obligations and other liabilities
|
|
|
22,372
|
|
|
|
24,403
|
|
|
Total liabilities
|
|
|
102,228
|
|
|
|
113,042
|
|
|
Commitments and contingencies
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
Preferred stock--$0.0001 par value; 10,000 shares authorized; no
|
|
|
|
|
|
|
|
|
|
shares issued and outstanding
|
|
|
--
|
|
|
|
--
|
|
|
Common stock--$0.0001 par value; 250,000 shares authorized;
|
|
|
|
|
|
|
|
|
|
43,933 and 45,772 shares issued and outstanding at
|
|
|
|
|
|
|
|
|
|
January 1, 2011 and January 2, 2010, respectively
|
|
|
4
|
|
|
|
5
|
|
|
Additional paid-in capital
|
|
|
49,947
|
|
|
|
128,262
|
|
|
Retained earnings
|
|
|
579,127
|
|
|
|
505,885
|
|
|
Accumulated other comprehensive loss
|
|
|
(3,648
|
)
|
|
|
(4,356
|
)
|
|
Total stockholders' equity
|
|
|
625,430
|
|
|
|
629,796
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
727,658
|
|
|
$
|
742,838
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
January 1,
2011
|
|
January 2,
2010
|
|
Operating Activities
|
|
|
|
|
|
Net income
|
|
$
|
73,242
|
|
|
$
|
73,092
|
|
|
Adjustments to reconcile net income to cash provided by operating
activities:
|
|
|
|
|
|
Depreciation of property and equipment
|
|
|
11,797
|
|
|
|
11,887
|
|
|
Loss on disposal of property and equipment
|
|
|
21
|
|
|
|
33
|
|
|
Amortization of other intangible assets and other assets
|
|
|
7,494
|
|
|
|
7,842
|
|
|
Stock compensation expense
|
|
|
40,324
|
|
|
|
43,974
|
|
|
Income tax benefit from employee stock-based awards
|
|
|
3,295
|
|
|
|
2,422
|
|
|
Excess income tax benefit from employee stock-based awards
|
|
|
(2,412
|
)
|
|
|
(1,862
|
)
|
|
Deferred income taxes
|
|
|
(552
|
)
|
|
|
1,896
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
Accounts receivable
|
|
|
11,342
|
|
|
|
(19,657
|
)
|
|
Inventories
|
|
|
(7,811
|
)
|
|
|
(3,216
|
)
|
|
Prepaid expenses and other assets
|
|
|
(5,321
|
)
|
|
|
3,362
|
|
|
Accounts payable
|
|
|
(777
|
)
|
|
|
8,036
|
|
|
Accrued expenses
|
|
|
(2,590
|
)
|
|
|
(825
|
)
|
|
Deferred income on shipments to distributors
|
|
|
(2,343
|
)
|
|
|
6,871
|
|
|
Income taxes
|
|
|
(7,774
|
)
|
|
|
(12,914
|
)
|
|
Net cash provided by operating activities
|
|
|
117,935
|
|
|
|
120,941
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
Purchases of available-for-sale investments
|
|
|
(357,777
|
)
|
|
|
(237,968
|
)
|
|
Proceeds from sales and maturities of marketable securities
|
|
|
352,779
|
|
|
|
153,275
|
|
|
Purchases of property and equipment
|
|
|
(13,850
|
)
|
|
|
(8,943
|
)
|
|
Purchases of other assets
|
|
|
(8,372
|
)
|
|
|
(6,408
|
)
|
|
Acquisitions of businesses, net of cash acquired
|
|
|
(28,021
|
)
|
|
|
(4,300
|
)
|
|
Net cash used in investing activities
|
|
|
(55,241
|
)
|
|
|
(104,344
|
)
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
Proceeds from issuance of common stock, net of shares withheld for
taxes
|
|
|
18,055
|
|
|
|
25,187
|
|
|
Excess income tax benefit from employee stock-based awards
|
|
|
2,412
|
|
|
|
1,862
|
|
|
Repurchases of common stock
|
|
|
(140,331
|
)
|
|
|
(20,181
|
)
|
|
Net cash provided by (used in) financing activities
|
|
|
(119,864
|
)
|
|
|
6,868
|
|
|
|
|
|
|
|
|
Increase (decrease) in cash and cash equivalents
|
|
|
(57,170
|
)
|
|
|
23,465
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
195,737
|
|
|
|
172,272
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
138,567
|
|
|
$
|
195,737
|
|
Silicon Laboratories Inc.
Shannon Pleasant, 512-464-9254
shannon.pleasant@silabs.com
Source: Silicon Laboratories Inc.
News Provided by Acquire Media